Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00400764
Status:
TERMINATED
Last Update Posted:
2011-11-23
First Post:
2006-11-15
Brief Title:
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade CD20 Non-Hodgkins Lymphomas
Sponsor:
Genentech Inc
Organization:
Genentech Inc